![OCT OI](http://old.institutmacula.com/wp-content/uploads/OCT-OI-300x110.jpg)
· 25/09/2022
MANTRA: evaluating the association between retinal sensitivity and retinal flow in AMD
![velodrome](http://old.institutmacula.com/wp-content/uploads/velodrome-300x110.jpg)
· 22/05/2022تسجيل
VELODROME: efficacy, safety and pharmacokinetics of ranibizumab 100 mg/ml through a PDS in patients with nDMAE
![talon](http://old.institutmacula.com/wp-content/uploads/talon-300x110.jpg)
· 15/05/2022
TALON (Extension): efficacy and safety of brolucizumab 6 mg in a maximum interval dosing schedule of 20 weeks for patients with nDMAE
![AG RETINO OS](http://old.institutmacula.com/wp-content/uploads/AG-RETINO-OS-300x110.jpg)
· 15/05/2022
GALE: evaluating the long-term safety and efficacy of intravitreal pegcetacoplan in patients with GA secondary to AMD
![MULTICOLOR](http://old.institutmacula.com/wp-content/uploads/MULTICOLOR-300x110.jpg)
· 11/04/2022تسجيل
IONIS: safety and efficacy of multiple doses of IONIS-FB-LRX
![OCT](http://old.institutmacula.com/wp-content/uploads/OCT2-300x110.jpg)
· 04/04/2022
Avonelle X: long-term safety and tolerability of the administration of intravitreal injections of Faricimab
![Distrofia coroidea areolar central](http://old.institutmacula.com/wp-content/uploads/Distrofia-coroidea-areolar-central1-300x110.jpg)
· 15/02/2022تسجيل
RADIS: Observational Study of Rare Retinal Pathologies
![retinosi pigmentaria](http://old.institutmacula.com/wp-content/uploads/retinosi-3-300x110.jpg)
· 18/11/2020
Phase I/IIa study in subjects with Pigmentary Retinosis
![KODIAC2](http://old.institutmacula.com/wp-content/uploads/KODIAC2-300x110.jpg)
· 18/11/2020
KODIAK: A phase II study in patients with the exudative form of AMD
![entrev autofluo DMAE atrofica (RGB)](http://old.institutmacula.com/wp-content/uploads/entrev-autofluo-DMAE-atrofica-RGB-300x110.jpg)
· 18/11/2020تسجيل
REVERS: Study using postbiotics in AMD patients
![F6](http://old.institutmacula.com/wp-content/uploads/F6-300x110.jpg)
· 14/02/2020
Clinical trial OAKS-DERBY: efficacy and safety of pegcetacoplan in the treatment of geographic atrophy secondary to AMD
![talon](http://old.institutmacula.com/wp-content/uploads/talon-300x110.jpg)
· 26/11/2019
TALON clinical trial: Efficacy and safety of brolacizumab in the treatment of exudative AMD
![IM_Captura-4-1024x681](http://old.institutmacula.com/wp-content/uploads/IM_Captura-4-1024x6811-300x110.jpg)
· 13/11/2019تسجيل
Research project MICROBEYEOME
![DMAE exsudativa (1)](http://old.institutmacula.com/wp-content/uploads/DMAE-exsudativa-1-300x110.jpg)
· 09/04/2019
LUCERNE clinical trial: efficacy and safety of FARICIMAB regarding aflibercept in the treatment of exudative age-related macular degeneration
![STARGARDT_BN](http://old.institutmacula.com/wp-content/uploads/STARGARDT_BN-300x110.jpg)
· 10/05/2018
Clinical trial OPH2005: Efficacy and safety of Zimura in the treatment of Stargardt’s disease